Kindstar Globalgene Technology, Inc. repurchased 17,000 ordinary shares on 08 June 2026 through on-exchange transactions, paying an aggregate HKD 18,020.22 at prices ranging between HKD 1.03 and HKD 1.05 per share. The volume-weighted average repurchase price stood at HKD 1.0471.

Following the transaction, issued shares (excluding treasury shares) slipped from 1.03 billion to 1.03 billion, representing a 0.00164% contraction, while treasury share holdings increased to 7.08 million. Total issued share capital remained at 1.04 billion shares.

The buyback forms part of a mandate approved on 05 June 2026 that authorises the repurchase of up to 103.43 million shares, equivalent to 10% of the company’s issued shares on the authorisation date. To date, 17,000 shares—0.01643% of the mandate limit—have been utilised.

In line with Hong Kong Listing Rules, Kindstar Global is subject to a moratorium on issuing new shares or disposing of treasury shares until 08 July 2026. The company confirmed that the repurchase complied with all applicable Main Board requirements and that no changes have been made to the explanatory statement filed on 24 April 2026.